Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Government monitoring glanders outbreaks in Turkey
Keepers of all Equidae are being reminded to maintain high standards of biosecurity and report any susect clinical signs promptly.

Equine owners urged to maintain high standards of biosecurity

Government officials are monitoring an outbreak of glanders in Turkey after the World Health Organisation (OIE) reported three cases of the disease in the country.

Glanders is an often-fatal condition caused by the bacteria Burkholderia malle, primarily affecting horses, donkeys and mules. The disease is spread through close contact with infected animals, or via food and water contaminated with discharges from the respiratory tract or ulcerated skin lesions of contaminated animals. 


On Friday (10 January), Defra/the APHA's International Disease Monitoring Team published a preliminary outbreak assessment of the situation after glanders was reported in Turkey for the first time since 2017. 


The first three of the outbreaks were confirmed on the 23 December 2019 during a routine screening. Two of these outbreaks were identified in the Mudurnu district in North-West Turkey, where 10 out of 85 susceptible horses tested positive for the disease and were subsequently culled.


Officials identified the third case in the Adalar Region of Istanbul, where certain permissions and conditions must be met to move horses in line with the 2018/1301 EC Directive. The animals are reported to have been brought into the district illegally, without microchips, identification documents or veterinary health certificates. 


‘All horses within the district were subsequently subject to serological and mallein tests for Glanders,' the Assessment notes. 'Quarantine, cleansing and disinfection measures have been applied, and equine movement in and out of the districts have been prohibited. All horses in the district will be subject to a follow-up test 20 days after initial testing.’


A fourth outbreak was reported on 30 December 2019 in a single horse in the Merkez district, some 260km south-west of the initial outbreaks. A private veterinary surgeon suspected glanders via the clinical signs and a mallei test identified the disease. This region is not approved for export of Equidae to the EU.

The International Disease Team said that it is continuing to monitor the situation and is reminding keepers of all Equidae ‘to maintain high standards of biosecurity and report any suspect clinical signs promptly.’

For more information about glanders and its clinical signs, vist at www.oie.int

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.